基因替代疗法用于CDKL5缺乏症疾病的临床前研究
Gregory Voronin1, Jana Narasimhan1, Jamila Gittens1
1PTC Therapeutics, Inc, 500 Warren Corporate Center Drive, Warren, NJ 07059, USA.
概括
使用AAV9.Syn.hCDKL5的基因疗法对循环素依赖的类激酶5 (CDKL5) 缺乏障碍 (CDD) 显示出希望. 在小鼠中,脑内静脉输送改善了病理和行为,证明了治疗这种罕见的神经发育疾病的潜力.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 循环素依赖性酶类5 (CDKL5) 缺乏障碍 (CDD) 是一种罕见的神经发育状况.
- CDKL5基因的突变导致CDD,影响大脑发育和功能.
- CDKL5对神经元发育至关重要,包括轴突生长和突触形成.
研究的目的:
- 开发和测试一种基因疗法载体用于CDD.
- 为了评估腺相关病毒 (AAV) 9.Syn.hCDKL5 的有效性,该病毒通过脑内静脉输入 (ICV) 输送. 在CDD的小鼠模型中.
主要方法:
- 在突触激素促进体 (AAV9.Syn.hCDKL5) 下设计了一种表达人类CDKL5基因的AAV9载体.
- 通过常规静脉注射给药AAV9.Syn.hCDKL5 在新生儿男性Cdkl5淘汰赛小鼠中注射.
- 评估生物分布,生物活性 (EB2酸化),病理和行为结果.
主要成果:
- 与其他方法相比,AAV9.Syn.hCDKL5的脑内静脉输送导致了更广泛的生物分布.
- 通过增加CDKL5基质 (EB2) 的酸化,治疗显示出生物活性.
- 在特定的载体基因组剂量下观察到功能改善和病理减少,需要广泛的神经转移.
结论:
- 通过AAV9.Syn.hCDKL5的脑内静脉输送,为CDD基因疗法提供了概念证明.
- 基因治疗载体的广泛分布对于CDD模型中的功能恢复至关重要.
- 这种方法有可能用于治疗CDKL5缺乏症患者.
关键词:
AAV9AV9 AAV9 AAV9 AAV9 AAV9 AAV9 AAV9 AAV9 AAV9一个CDD一个CDD.在CDKL5中,CDKL5为CDKL5.生物分销生物分销药物的发现和开发.基因治疗的基因疗法分子治疗的分子疗法.疾病的小鼠模型.药理动力学是药理动力学的一个方面.管理的途径的管理路径.更多相关视频
06:48Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
Published on: August 7, 2015
21.2K
11:13Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
Published on: April 7, 2016
9.1K
相关概念视频
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
In-vitro Mutagenesis
13.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.9K
